10058-F4 Catalog No.:M8326-2 Epub 2011 Aug 10

Epub 2011 Aug 10

and L-aspartic acid with photosensitizing activity

the anti-MM activity of ACY-1215 in combination with bortezomib was confirmed using 2 different xenograft SCID mouse models

1007/s40265-019-01181-2

Ki8751 (5 mg/kg) completely inhibits tumor growth without affecting body weight

10058-F4 Catalog No.:M8326-2 Epub 2011 Aug 1010058 F4 is a potent and selective c Myc inhibitor, which markedly increases valproic acid induced cell death in Jurkat and CCRF CEM T lymphoblastic leukemia cells. 10058 F4 inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. 10058 F4 induces cell cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Product information CAS